These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19491724)

  • 1. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity.
    Anderson C; Pahk P; Blaha GR; Spindel GP; Alster Y; Rafaeli O; Marx JL
    Retina; 2009 Sep; 29(8):1188-92. PubMed ID: 19491724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
    Adam MK; Covert DJ; Stepien KE; Han DP
    Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.
    Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M
    Glob J Health Sci; 2015 Jun; 8(3):59-64. PubMed ID: 26493438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY; Chan WM; Li H; Lai RY; Lam DS
    Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
    Martínez-Costa L; Victoria Ibañez M; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
    Can J Ophthalmol; 2013 Oct; 48(5):400-5. PubMed ID: 24093187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
    Kahn JB; Haberman ID; Reddy S
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series.
    Bienfang D; Coblyn JS; Liang MH; Corzillius M
    J Rheumatol; 2000 Nov; 27(11):2703-6. PubMed ID: 11093457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
    Tanga L; Centofanti M; Oddone F; Parravano M; Parisi V; Ziccardi L; Kroegler B; Perricone R; Manni G
    Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):715-21. PubMed ID: 21253758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hydroxychloroquine toxicity by Texas ophthalmologists.
    Blomquist PH; Chundru RK
    J Rheumatol; 2002 Aug; 29(8):1665-70. PubMed ID: 12180726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G; Tassi D
    Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
    Kim JW; Kim YY; Lee H; Park SH; Kim SK; Choe JY
    J Rheumatol; 2017 Nov; 44(11):1674-1679. PubMed ID: 28864645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Hydroxy)-chloroquine retinal toxicity: two case reports and safety guidelines.
    Herman K; Leys A; Spileers W
    Bull Soc Belge Ophtalmol; 2002; (284):21-9. PubMed ID: 12161987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.